Abstract
BackgroundTumour necrosis factor (TNF) blockade is highly effective for the treatment of spondyloarthritis (SpA). Unfortunately, in axial SpA, anti-TNF therapy discontinuation leads to fast disease relapse in almost all patients....
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have